학술논문

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study
Document Type
Article
Source
In: Cancer Immunology, Immunotherapy. (Cancer Immunology, Immunotherapy, November 2023, 72(11):3665-3682)
Subject
Language
English
ISSN
14320851
03407004